Net Cash Provided by (Used in) Operating Activities |
-989K |
USD |
-166% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
1.1M |
USD |
+450% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-37.8K |
USD |
-119% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
250M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
155M |
shares |
+0.38% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
73.1K |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
549K |
USD |
+85.7% |
Q4 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q4 2023 |
FY 2023 |
Payments to Acquire Property, Plant, and Equipment |
14.9K |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
549K |
USD |
+85.7% |
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
3.7M |
USD |
+52.9% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
549K |
USD |
+85.7% |
Q4 2024 |
FY 2024 |
Interest Expense |
2.86K |
USD |
|
Q3 2023 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |